Announced
Financials
Tags
United States
biotechnology
Domestic
Friendly
Public
Majority
Pending
Biotechnology
Single Bidder
Acquisition
Tender Offer
Synopsis
Biomed Industries, a bio-pharmaceutical company, offered to acquire Quince Therapeutics, a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics, for $90m. "We believe our offer is very compelling as it provides Quince' shareholders with a highly certain and significant return and the ability to obtain liquidity for their shares, as well as the upside potential of Biomed," Lloyd L. Tran, Biomed Industries Chairman and CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.